Repros Therapeutics Inc Stock

Stocks

27/01/18	Repros Announces Negative Opinion From the EMA for Enclomiphene	GL
16/12/17	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency	GL
13/12/17	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU
13/12/17	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders	BU
12/12/17	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc	GL

02/04/15	Apple : Les valeurs à suivre sur les marchés américains
02/04/15	USA-Les valeurs à suivre à Wall Street

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REPROS THERAPEUTICS INC	-.--%	+0.74%	-	-	0
LONZA GROUP AG	+1.17%	-1.66%	-1.70%	+10.81%	46.86B
REVOLUTION MEDICINES, INC.	+0.25%	+1.65%	+399.22%	+647.65%	40.23B
BEONE MEDICINES AG	-0.27%	+4.45%	+11.81%	+60.81%	36.23B
IQVIA HOLDINGS INC.	+0.35%	+0.87%	+4.46%	-10.31%	34.72B
CELLTRION, INC.	+3.14%	+1.02%	+4.76%	+43.00%	27.89B
MEDPACE HOLDINGS, INC.	-0.73%	+11.84%	+34.39%	+134.44%	16.79B
ASCENDIS PHARMA A/S	+0.47%	-2.74%	-	-	16.74B
EUROFINS SCIENTIFIC SE	+1.33%	-5.40%	+2.81%	+8.31%	13.12B
ICON PUBLIC LIMITED COMPANY	-2.68%	-2.49%	-11.36%	-34.51%	12.7B
Average	+0.30%	+0.83%	+55.55%	+107.53%	27.25B
Weighted average by Cap.	+0.55%	+0.91%	+75.11%	+137.98%

Employees

Sector